40 related articles for article (PubMed ID: 38757343)
1. Daunorubicin induces GLI1‑dependent apoptosis in colorectal cancer cell lines.
Kim BR; Kim DY; Tran NL; Kim BG; Lee SI; Kang SH; Min BY; Hur W; Oh SC
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757343
[TBL] [Abstract][Full Text] [Related]
2. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
[TBL] [Abstract][Full Text] [Related]
3. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
[TBL] [Abstract][Full Text] [Related]
4. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
Xu M; Wang J; Li H; Zhang Z; Cheng Z
Aging (Albany NY); 2020 Dec; 13(1):1017-1031. PubMed ID: 33291082
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-cCSC1 modulates cancer stem cell properties in colorectal cancer via activation of the Hedgehog signaling pathway.
Zhou H; Xiong Y; Peng L; Wang R; Zhang H; Fu Z
J Cell Biochem; 2020 Mar; 121(3):2510-2524. PubMed ID: 31680315
[TBL] [Abstract][Full Text] [Related]
6. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
[TBL] [Abstract][Full Text] [Related]
7. Sustained CHK2 activity, but not ATM activity, is critical to maintain a G1 arrest after DNA damage in untransformed cells.
García-Santisteban I; Llopis A; Krenning L; Vallejo-Rodríguez J; van den Broek B; Zubiaga AM; Medema RH
BMC Biol; 2021 Feb; 19(1):35. PubMed ID: 33607997
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog Signaling: An Achilles' Heel in Cancer.
Niyaz M; Khan MS; Mudassar S
Transl Oncol; 2019 Oct; 12(10):1334-1344. PubMed ID: 31352196
[TBL] [Abstract][Full Text] [Related]
9. Next-Generation Hedgehog/GLI Pathway Inhibitors for Cancer Therapy.
Peer E; Tesanovic S; Aberger F
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30991683
[TBL] [Abstract][Full Text] [Related]
10. Nuclear localization and Overexpression of Smoothened in Pancreatic and Colorectal Cancers.
Niyaz M; Khan MS; Wani RA; Shah OJ; Besina S; Mudassar S
J Cell Biochem; 2019 Jul; 120(7):11941-11948. PubMed ID: 30784110
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Hedgehog Pathway in Cancer: Current Evidence and Future Perspectives.
Girardi D; Barrichello A; Fernandes G; Pereira A
Cells; 2019 Feb; 8(2):. PubMed ID: 30759860
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells.
Sari IN; Phi LTH; Jun N; Wijaya YT; Lee S; Kwon HY
Cells; 2018 Nov; 7(11):. PubMed ID: 30423843
[TBL] [Abstract][Full Text] [Related]
13. A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.
Rahman MM; Hazan A; Selway JL; Herath DS; Harwood CA; Pirzado MS; Atkar R; Kelsell DP; Linton KJ; Philpott MP; Neill GW
Cancer Res; 2018 May; 78(10):2577-2588. PubMed ID: 29463581
[TBL] [Abstract][Full Text] [Related]
14. Cytarabine and daunorubicin for the treatment of acute myeloid leukemia.
Murphy T; Yee KWL
Expert Opin Pharmacother; 2017 Nov; 18(16):1765-1780. PubMed ID: 29017371
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy.
Pak E; Segal RA
Dev Cell; 2016 Aug; 38(4):333-44. PubMed ID: 27554855
[TBL] [Abstract][Full Text] [Related]
16. Sonic hedgehog and Gli1 expression predict outcome in resected pancreatic adenocarcinoma.
Maréchal R; Bachet JB; Calomme A; Demetter P; Delpero JR; Svrcek M; Cros J; Bardier-Dupas A; Puleo F; Monges G; Hammel P; Louvet C; Paye F; Bachelier P; Le Treut YP; Vaillant JC; Sauvanet A; André T; Salmon I; Devière J; Emile JF; Van Laethem JL
Clin Cancer Res; 2015 Mar; 21(5):1215-24. PubMed ID: 25552484
[TBL] [Abstract][Full Text] [Related]
17. SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features.
Li T; Liao X; Lochhead P; Morikawa T; Yamauchi M; Nishihara R; Inamura K; Kim SA; Mima K; Sukawa Y; Kuchiba A; Imamura Y; Baba Y; Shima K; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S; Qian ZR
Ann Surg Oncol; 2014 Dec; 21(13):4164-73. PubMed ID: 25023548
[TBL] [Abstract][Full Text] [Related]
18. Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding.
Agyeman A; Jha BK; Mazumdar T; Houghton JA
Oncotarget; 2014 Jun; 5(12):4492-503. PubMed ID: 24962990
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
